Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Survival and Economic Benefits of Implementing Evidence-Based Tobacco Treatment Across US Cancer Care.

JCO oncology practice·2026

Same author

Associations of lung and bronchus cancer incidence and ambient temperature and severe drought: a population-based study.

BMC public health·2026

Same author

Building climate-resilient, low-carbon health systems: A knowledge, attitudes and practices study with the primary healthcare workforce in Lebanon.

The journal of climate change and health·2026

Same author

Survival Outcomes of a Smoking Cessation Treatment Program After Diagnosis of Bladder Cancer.

European urology oncology·2026

Same author

Repurposing semaglutide as an adjunctive treatment for cocaine use disorder: protocol for a randomised controlled trial.

BMJ open·2026

Same author

Emotion regulation or dual task? Dissociation of neural and behavioral measures.

bioRxiv : the preprint server for biology·2026

Search research articles

Related Experiment Video

Updated: Jun 2, 2025

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Randomized Clinical Trial.

Paul M Cinciripini¹, Jennifer A Minnix¹, George Kypriotakis¹

¹Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston.

JAMA Internal Medicine

|January 13, 2025

Summary

Integrated care (IC) for smoking cessation in lung cancer screening (LCS) showed higher abstinence rates than quitline (QL) or QL plus (QL+) strategies. IC offers the best opportunity for quitting, with QL+ being a viable option in low-resource settings.

More Related Videos

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

Related Experiment Videos

Last Updated: Jun 2, 2025

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

Area of Science:

Oncology
Public Health
Behavioral Science

Background:

Optimal smoking cessation interventions within lung cancer screening (LCS) programs remain undefined.
Lung cancer screening identifies smokers who may benefit from targeted tobacco cessation support.

Purpose of the Study:

To compare the efficacy of three tobacco treatment strategies with increasing integration and intensity within an LCS setting.
Evaluate quitline (QL), QL plus (QL+), and integrated care (IC) for smoking cessation.

Main Methods:

A randomized clinical trial involving 630 current smokers eligible for LCS.
Participants were randomized into QL, QL+, or IC groups, receiving varying levels of counseling and medication support.
Outcomes included self-reported abstinence at 3 and 6 months, with a change from biochemical verification due to the COVID-19 pandemic.

Main Results:

Integrated care (IC) demonstrated significantly higher abstinence rates at 3 months (37.1%) compared to QL (25.2%) and QL+ (27.1%).
At 6 months, IC maintained the highest abstinence rate (32.4%), outperforming QL (20.5%) and showing a sustained advantage over QL+ (27.6%).
Bayesian analysis confirmed a higher probability of absolute risk differences favoring IC over both QL and QL+ at 3 and 6 months.

Conclusions:

Integrated care, combining medication and intensive counseling within the LCS environment, offers the most effective smoking cessation support.
While IC consistently outperformed other strategies, QL+ showed comparable results at 6 months, suggesting its utility in resource-limited settings.
These findings highlight the importance of tailored, integrated interventions for smoking cessation in high-risk populations undergoing lung cancer screening.